Evidence map›Paper›PMID 38050128›Full record

ArticleJournal of medical genetics2024

Short-read whole genome sequencing identifies causative variants in most individuals with previously unexplained aniridia.

Hildegard Nikki Hall, David Parry, Mihail Halachev, Kathleen A Williamson, Kevin Donnelly, Jose Campos Parada, Shipra Bhatia, Jeffrey Joseph, Simon Holden, Trine E Prescott and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Structural Variant Disrupting the Expression of the RemoteInternational journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Hildegard Nikki HallInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK nikki.hall@ed.ac.uk.ORCID 0000-0001-7082-1523
David ParryInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Mihail HalachevInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Kathleen A WilliamsonInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Kevin DonnellyInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Jose Campos ParadaInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Shipra BhatiaInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Jeffrey JosephMRC Human Genetics Unit, The University of Edinburgh, Edinburgh, UK.
Simon HoldenEast Anglia Regional Genetics Service, Addenbrooke's Hospital, Cambridge, UK.
Trine E PrescottDepartment of Medical Genetics, Telemark Hospital, Skien, Norway.
Pierre BitounConsultations de Génétique médicale, Service de Pédiatrie, CHU Paris-Nord, Hôpital Jean Verdier, Bondy, France.
Edwin P KirkCentre for Clinical Genetics, Sydney Children's Hospital Randwick, Randwick, New South Wales, Australia.
Ruth Newbury-EcobDepartment of Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Katherine LachlanUniversity Hospital Southampton, NHS Foundation Trust Wessex Clinical Genetics Service, Southampton, UK.
Juan BernarDepartment of Genetics, Hospital Ruber Internacional, Madrid, Spain.
Veronica van HeyningenMRC Human Genetics Unit, The University of Edinburgh, Edinburgh, UK.
David R FitzPatrickInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Alison MeynertInstitute of Genetics and Cancer, The University of Edinburgh MRC Human Genetics Unit, Edinburgh, UK.
Institute of Genetics and Cancer · GBAddenbrooke's Hospital · GBHôpital Jean-Verdier · FRHospital Ruber Internacional · ESIllumina (United Kingdom) · GBSydney Children's Hospital · AUTelemark Hospital · NOUniversity Hospitals Bristol NHS Foundation Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

Medical Research Council MC_UU_00007/2Medical Research Council MC_UU_00007/3Medical Research Council MC_UU_00035/7Wellcome Trust
6 · The paper itself

Abstract

backgroundClassic aniridia is a highly penetrant autosomal dominant disorder characterised by congenital absence of the iris, foveal hypoplasia, optic disc anomalies and progressive opacification of the cornea. >90% of cases of classic aniridia are caused by heterozygous, loss-of-function variants affecting the

methodsShort-read whole genome sequencing was performed on 51 (39 affected) individuals from 37 different families who had screened negative for mutations in the

resultsLikely causative mutations were identified in 22 out of 37 (59%) families. In 19 out of 22 families, the causative genomic changes have an interpretable deleterious impact on the

conclusionWhole genome sequencing proves to be an effective diagnostic test in most individuals with previously unexplained aniridia.

Indexed as

AniridiaEye AbnormalitiesExonsEye ProteinsHomeodomain ProteinsHumansMutationPAX6 Transcription FactorPedigreeEye ProteinsHomeodomain ProteinsPAX6 Transcription FactorEye DiseasesGenetic TestingMutation

Identifiers

PMID38050128
PMCPMC7615962
OpenAlexW4389207608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.